Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (11-20 of 220) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|July 19, 2002
Hepatitis B e Antigen--the dangerous endgame of hepatitis BT Jake Liang, Marc Ghany
Gastroenterology|May 1, 2020
Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical ReviewSiyuan Ding, T Jake Liang
Journal of Hepatology|July 20, 2020
Hepatitis B virus - recent therapeutic advances and challenges to cureKarim Mouzannar, T Jake Liang
Hepatology (Baltimore, Md.)|October 28, 2003
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infectionDavid Milich, T Jake Liang
Journal of Virology|May 8, 2009
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomesYaron Rotman, T Jake Liang
Journal of Hepatology|November 19, 2008
Settling the "score" with liver cancerChristopher Koh, T Jake Liang
Medecine Sciences : M/S|April 10, 2015
[Transplantation of iPS-derived hepatocytes into a mouse liver: a new murine model of hepatitis C virus infection]Arnaud Carpentier, T Jake Liang
Gastroenterology|October 28, 2004
Pathogenesis of hepatitis C-associated hepatocellular carcinomaT Jake Liang, Theo Heller
Hepatology (Baltimore, Md.)|December 4, 2003
Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?Kittichai Promrat, T Jake Liang
Gastroenterology|April 6, 2007
Drug targets and molecular mechanisms of drug resistance in chronic hepatitis BMarc Ghany, T Jake Liang
Pageof 22

Showing results (11-20 of 220) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|July 19, 2002
Hepatitis B e Antigen--the dangerous endgame of hepatitis BT Jake Liang, Marc Ghany
Gastroenterology|May 1, 2020
Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical ReviewSiyuan Ding, T Jake Liang
Journal of Hepatology|July 20, 2020
Hepatitis B virus - recent therapeutic advances and challenges to cureKarim Mouzannar, T Jake Liang
Hepatology (Baltimore, Md.)|October 28, 2003
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infectionDavid Milich, T Jake Liang
Journal of Virology|May 8, 2009
Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomesYaron Rotman, T Jake Liang
Journal of Hepatology|November 19, 2008
Settling the "score" with liver cancerChristopher Koh, T Jake Liang
Medecine Sciences : M/S|April 10, 2015
[Transplantation of iPS-derived hepatocytes into a mouse liver: a new murine model of hepatitis C virus infection]Arnaud Carpentier, T Jake Liang
Gastroenterology|October 28, 2004
Pathogenesis of hepatitis C-associated hepatocellular carcinomaT Jake Liang, Theo Heller
Hepatology (Baltimore, Md.)|December 4, 2003
Chemokine systems and hepatitis C virus infection: is truth in the genes of the beholders?Kittichai Promrat, T Jake Liang
Gastroenterology|April 6, 2007
Drug targets and molecular mechanisms of drug resistance in chronic hepatitis BMarc Ghany, T Jake Liang
Pageof 22